Further supporting the notion of an inflammation‐resolving role of this cytokine, IL‐22 has recently been shown to potentially modulate the IL‐23/IL‐17 inflammatory axis in RA patients by down‐regulating IL‐23 and IL‐17RC expression in fibroblast‐like synoviocytes (32). Here, IL17RC is linked to rheumatoid arthritis.